Some error occured while loading the Quick View. Please close the Quick View and try reloading the page.
A robust revision, including many entirely new chapters addressing policy, the latest treatment approaches, and special topics, the Sixth Edition of The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment offers a comprehensive and compelling review of this ever-evolving field. New sections address important topics that have gained prominence or become the focus of increased research attention since the Fifth Edition was released. For example, substance use and other psychiatric disorders often co-occur, and the resulting dual disorder is frequently associated with greater symptom severity and worse long-term prognosis than either disorder alone. Accordingly, the section on psychiatric comorbidity covers the epidemiology, assessment, and treatment of substance use disorders (SUDs) that co-occur with psychotic, mood, anxiety, eating, attention-deficit/hyperactivity, or trauma-related disorders. The section devoted to special populations has been revamped, and the topics have been thoroughly updated, some now covered by new contributors and others completely new to this edition. SUDs among women (including perinatal issues), adolescents, patients with chronic pain, sexual and gender minority populations, and older adults are addressed in detailed chapters, as are behavioral addictive disorders and cross-cultural aspects of substance-related and addictive disorders. Finally, the editors have included a section devoted to critically important topics in public health, including the U.S. opioid epidemic, cannabis policy and use, HIV/AIDS and hepatitis C, nicotine and public health, and the prevention of SUDs.
New or noteworthy coverage includes the following:
• A
chapter devoted to the legal and practical aspects of addiction in the
occupational sphere, designed for clinicians who treat people with SUDs
and/or develop workplace testing programs, employee assistance programs, and
occupational drug/alcohol policies for these workers.
• A chapter that
surveys the growing literature supporting the use of mindfulness, exercise,
and other "mind and body" practices (e.g., yoga, acupuncture, tai chi) as
complements or alternatives to standard SUD treatment models.
• A
chapter devoted to hallucinogens, which clarifies their actions,
psychoactive effects, historical uses, potential therapeutic benefits, and
neural mechanisms, and both identifies their risks and seeks to dispel some
of the misconceptions that have continued to surround them.
• A suite of
chapters devoted to cannabis, encompassing a review of its neurobiology and
history, a survey of effective treatment approaches and harm-reduction
strategies for cannabis use disorder, and a consideration of evolving public
policy around cannabis use.
• A trio of chapters devoted to nicotine and
tobacco, encompassing a review of neurobiology, a survey of clinical
assessment tools, a summary of the research base for effective treatments
for tobacco use disorder, and a consideration of public health policy and
interventions regarding tobacco use.
Evidence-based, down to earth, and meticulously edited, the new Sixth Edition of The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment is an essential resource for clinicians who treat SUDs in a variety of settings—from examining rooms to emergency departments, and from hospitals to recovery facilities.
This sixth edition continues to be a one-stop reference text in this area. It looks at an expanded, up-to-date, wide range of topics pertinent to the clinical aspects of these disorders. Each section is comprehensive and extensive references are available if one wants more detailed information in any one area.
— Michael Easton, MD
Kathleen T. Brady, M.D., Ph.D., is Distinguished University Professor and Vice President for Research in the Department of Psychiatry and Behavioral Sciences, Clinical Neuroscience Division, as well as Director of the South Carolina Clinical and Translational Research Institute, at the Medical University of South Carolina, in Charleston, South Carolina.
Frances R. Levin, M.D., is Kennedy-Leavy Professor of Psychiatry at Columbia University Medical Center, and Chief of the Division on Substance Use Disorders at the New York State Psychiatric Institute in New York, New York.
Marc Galanter, M.D., is Professor of Psychiatry and Director of the Division of Alcoholism and Drug Abuse at New York University School of Medicine in New York, New York.
Herbert D. Kleber, M.D., was Professor of Psychiatry and Director of the Division on Substance Abuse at Columbia University in New York, New York.
Contributors
Part I: The Basis of Substance-Related
and Addictive Disorders
Chapter 1. Neurocircuitry of
Addiction
Chapter 2. Genetics and Epigenetics of Addiction
Chapter
3. Epidemiology of Addiction
Chapter 4. Substance Use Disorder Diagnoses
in DSM-5
Part II: Assessment and Treatment
Chapter 5.
Assessment
Chapter 6. Screening and Brief Intervention
Chapter 7.
Treating Addiction Like a Chronic Illness: A Practical Clinical
Model
Part III: Specific Drugs of Abuse: Neurobiology and
Pharmacotherapy
Chapter 8. Neurobiology of Alcohol
Chapter
9. Treatment of Alcohol-Related Disorders
Chapter 10. Neurobiology of
Stimulants
Chapter 11. Treatment of Stimulant-Related
Disorders
Chapter 12. Neurobiology of Opioids
Chapter 13. Methadone
and Buprenorphine Maintenance Treatment of Opioid-Related
Disorders
Chapter 14. Opioid Antagonist Treatment of Opioid-Related
Disorders
Chapter 15. Neurobiology and Treatment of Hallucinogen Use
Disorder
Chapter 16. Neurobiology of Marijuana
Chapter 17. Treatment
of Cannabis-Related Disorders
Chapter 18. Neurobiology of Nicotine and
Tobacco
Chapter 19. Treatment of Tobacco-Related Disorders
Chapter
20. Neurobiology and Treatment of Sedative-, Hypnotic-, and
Anxiolytic-Related Disorders
Chapter 21. Neurobiology and Treatment of
Anabolic-Androgenic Steroid–Related Disorders
Part IV:
Nonpharmacotherapeutic Treatment Modalities
Chapter 22.
Psychodynamic Psychotherapy
Chapter 23. Cognitive-Behavioral
Therapy
Chapter 24. Contingency Management
Chapter 25. Motivational
Enhancement
Chapter 26. Alcoholics Anonymous and Twelve-Step
Facilitation
Chapter 27. Family Therapy
Chapter 28. Network
Therapy
Chapter 29. Digitally Delivered Therapies
Chapter 30.
Mindfulness, Exercise, and Other Alternative Approaches
Part V:
Public Health Issues
Chapter 31. The U.S. Opioid
Crisis
Chapter 32. Cannabis Policy and Use
Chapter 33. HIV/AIDS and
Hepatitis C
Chapter 34. Public Health and Nicotine
Chapter 35.
Prevention of Substance Use Disorders
Part VI: Special
Populations
Chapter 36. Substance-Related Disorders in
Women
Chapter 37. Substance-Related Disorders in Adolescents
Chapter
38. Substance-Related Disorders in Patients With Chronic Pain
Chapter
39. Substance Use and Related Disorders in Sexual and Gender Minority
Populations
Chapter 40. Cross-Cultural Aspects of Substance-Related and
Addictive Disorders
Chapter 41. Substance-Related Disorders in Older
Adults
Chapter 42. Behavioral Addictive Disorders
Part VII:
Psychiatric Comorbidity in Substance-Related Disorders
Chapter
43. Epidemiology of Co-Occurring Psychiatric and Substance Use
Disorders
Chapter 44. Mood Disorders
Chapter 45. Anxiety
Disorders
Chapter 46. Eating Disorders
Chapter 47.
Attention-Deficit/Hyperactivity Disorder
Chapter 48. Trauma- and
Stressor-Related Disorders
Chapter 49. Schizophrenia Spectrum and Other
Psychotic Disorders
Part VIII: Special Topics
Chapter 50.
Testing for Substances of Abuse
Chapter 51. Forensic Addiction
Psychiatry
Chapter 52. Medical Education on Addiction
Chapter 53.
Addiction in the Workplace
Index